Loading clinical trials...
Loading clinical trials...
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Conditions
Interventions
FOLFOXIRI
Locations
1
China
Ethics Committee of Renji Hospital, School of Medicine,Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
Start Date
November 1, 2016
Primary Completion Date
September 30, 2019
Completion Date
September 30, 2022
Last Updated
January 3, 2018
NCT06696768
NCT04929028
NCT04704661
NCT05489211
NCT04674267
NCT04657068
Lead Sponsor
RenJi Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions